Eric Winer

From Wikipedia, the free encyclopedia

Eric P. Winer, MD, is chief of the Division of Women's Cancers and director of the Breast Oncology Program in the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute in Boston, Massachusetts.[1] He is the Thompson Senior Investigator in Breast Cancer Research and a Professor of Medicine at Harvard Medical School.[2]

Biography and Education

Winer received his undergraduate degree in History and Russian/East European Studies from from Yale University in 1978 and graduated from the Yale School of Medicine in 1983.[3] He went on to complete residency training in internal medicine at Yale-New Haven Hospital, where he served as chief medical resident.[3]

From 1987-1989, Winer held a fellowship in hematology-oncology at Duke University Medical Center.[4] From 1989-1997 he was on the faculty at Duke University Medical Center and served as co-director of the Duke University Medical Center Multidisciplinary Breast Program.[1]

Winer joined Brigham and Women's Hospital and Dana-Farber in 1997 and was appointed director of the Breast Oncology Center.[1] Winer was named director of Dana-Farber’s Ambulatory Services in 2002.[3][5]

Other positions/titles

  • Member, ASCO Board of Directors-Executive Committee[6]
  • Member, ASCO Scientific Program Committee[7]
  • Chief scientific advisor, Susan G. Komen for the Cure Scientific Advisory Board[8]

Research

Winer is the principal investigator of the Dana-Farber/Harvard Cancer Center NCI SPORE (National Cancer Institute Specialized Program of Research Excellence) in breast cancer.[9] His research group focuses on improving care and quality of life for breast cancer patients through new drug treatments developed in clinical trials.[3] He also co-chairs the Breast Committee in the Alliance for Clinical Trials in Oncology,[10] a national clinical trials network.[11]

Articles

  • Anders, Carey K., et al. "Poly (ADP-Ribose) polymerase inhibition:“Targeted” therapy for triple-negative breast cancer." Clinical Cancer Research 16.19 (2010): 4702-4710.
  • Muss, Hyman B., et al. "Adjuvant chemotherapy in older women with early-stage breast cancer." New England Journal of Medicine 360.20 (2009): 2055-2065.
  • Hayes, Daniel F., et al. "HER2 and response to paclitaxel in node-positive breast cancer." New England Journal of Medicine 357.15 (2007): 1496-1506.
  • Partridge, Ann H., and Eric P. Winer. "Informing clinical trial participants about study results." JAMA: the journal of the American Medical Association 288.3 (2002): 363-365.
  • Burstein, Harold J., and Eric P. Winer. "Primary care for survivors of breast cancer." New England Journal of Medicine 343.15 (2000): 1086-1094.

Awards

  • Claire W. and Richard P. Morse Research Award, 2002[12]

References

  1. ↑ 1.0 1.1 1.2 "Eric P. Winer, MD,". dana-farber.org. Retrieved 2013-11-19. 
  2. ↑ "Eric P. Winer, MD, FASCO". ASCO.org. Retrieved 2013-11-12. 
  3. ↑ 3.0 3.1 3.2 3.3 "Eric P. Winer, M.D. « Women's Cancer Research Fund". Womenscancerresearchfund.org. Retrieved 2013-11-12. 
  4. ↑ "San Antonio Breast Cancer Symposium: Faculty - Faculty". Sabcs.org. 2010-10-05. Retrieved 2013-11-12. 
  5. ↑ "Meet Eric P. Winer, MD | ASCO Connection". Connection.asco.org. 2012-02-23. Retrieved 2013-11-12. 
  6. ↑ "Board of Directors". ASCO.org. Retrieved 2013-11-12. 
  7. ↑ "Scientific Program Committee | ASCO Annual Meeting". Am.asco.org. Retrieved 2013-11-12. 
  8. ↑ "Susan G. Komen® | About Us | Our People | Scientific Advisory Board | Scientific Advisory Board". Ww5.komen.org. 2013-10-03. Retrieved 2013-11-12. 
  9. ↑ "Organ Site-Specific SPOREs | Translational Research Program (TRP)". Trp.cancer.gov. Retrieved 2013-11-12. 
  10. ↑ rayogram. "BCRF :: Eric P. Winer, MD". Bcrfcure.org. Retrieved 2013-11-12. 
  11. ↑ "Alliance - About The Alliance". Allianceforclinicaltrialsinoncology.org. Retrieved 2013-11-12. 
  12. ↑ http://shareyourheart.org/research.htm


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.